Lundi 22 mai 2023 Voir aussi : Hugues de Thé Documents et médias Télécharger le programme pdf (380.33 Ko) Programme Colloque 09:15 - 09:30 Introduction Hugues de Thé 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 09:15 - 09:30 Colloque 09:30 - 10:00 New Approaches to Cancer Therapy Rene Bernards 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 09:30 - 10:00 Colloque 10:00 - 10:30 Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application Yves Pommier 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 10:00 - 10:30 Colloque 10:30 - 10:50 Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities Sophie Postel-Vinay 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 10:30 - 10:50 Colloque 11:20 - 11:50 Killing Cancer by DNA Damage Through Synthetic Lethality Thomas Helleday 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 11:20 - 11:50 Colloque 14:00 - 14:30 Metabolic Bases of Responses to Chemotherapy in Leukemia Jean-Emmanuel Sarry 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 14:00 - 14:30 Colloque 14:30 - 15:00 SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies Guillaume Bossis 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 14:30 - 15:00 Colloque 15:20 - 15:50 Non enregistré Microbially Derived Adjuvants for Cancer Chemotherapy Filipe Cabreiro 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 15:20 - 15:50 Colloque 15:50 - 16:20 Revisiting Chemotherapy Failure—From a Senescence Point-of-view Clemens Schmitt 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 15:50 - 16:20 Colloque 16:20 - 17:00 Conclusions Hugues de Thé 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 16:20 - 17:00 Voir aussi Hugues de Thé, chaire Oncologie cellulaire et moléculaire
Colloque 09:15 - 09:30 Introduction Hugues de Thé 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 09:15 - 09:30
Colloque 09:30 - 10:00 New Approaches to Cancer Therapy Rene Bernards 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 09:30 - 10:00
Colloque 10:00 - 10:30 Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application Yves Pommier 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 10:00 - 10:30
Colloque 10:30 - 10:50 Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities Sophie Postel-Vinay 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 10:30 - 10:50
Colloque 11:20 - 11:50 Killing Cancer by DNA Damage Through Synthetic Lethality Thomas Helleday 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 11:20 - 11:50
Colloque 14:00 - 14:30 Metabolic Bases of Responses to Chemotherapy in Leukemia Jean-Emmanuel Sarry 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 14:00 - 14:30
Colloque 14:30 - 15:00 SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies Guillaume Bossis 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 14:30 - 15:00
Colloque 15:20 - 15:50 Non enregistré Microbially Derived Adjuvants for Cancer Chemotherapy Filipe Cabreiro 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 15:20 - 15:50
Colloque 15:50 - 16:20 Revisiting Chemotherapy Failure—From a Senescence Point-of-view Clemens Schmitt 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 15:50 - 16:20
Colloque 16:20 - 17:00 Conclusions Hugues de Thé 22 mai 2023 Revisited Chemotherapy Salle 2, Site Marcelin Berthelot 22 mai 2023 16:20 - 17:00
